vs
Side-by-side financial comparison of Apollo Commercial Real Estate Finance, Inc. (ARI) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.
Apollo Commercial Real Estate Finance, Inc. is the larger business by last-quarter revenue ($73.3M vs $40.7M, roughly 1.8× PETMED EXPRESS INC). Apollo Commercial Real Estate Finance, Inc. runs the higher net margin — 39.9% vs -26.0%, a 65.8% gap on every dollar of revenue. On growth, Apollo Commercial Real Estate Finance, Inc. posted the faster year-over-year revenue change (4.0% vs -23.3%). Over the past eight quarters, Apollo Commercial Real Estate Finance, Inc.'s revenue compounded faster (-4.6% CAGR vs -20.9%).
Apollo Commercial Real Estate Finance, Inc. is a real estate investment trust that originates, acquires and manages commercial real estate debt assets including mortgages, mezzanine loans and mortgage-backed securities, primarily operating in the U.S. market to deliver consistent risk-adjusted returns.
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
ARI vs PETS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $73.3M | $40.7M |
| Net Profit | $29.2M | $-10.6M |
| Gross Margin | — | 23.3% |
| Operating Margin | 39.7% | -25.7% |
| Net Margin | 39.9% | -26.0% |
| Revenue YoY | 4.0% | -23.3% |
| Net Profit YoY | -28.2% | -1392.6% |
| EPS (diluted) | $0.19 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $73.3M | $40.7M | ||
| Q3 25 | $61.6M | $44.4M | ||
| Q2 25 | $70.9M | $51.2M | ||
| Q1 25 | $65.8M | $50.8M | ||
| Q4 24 | $70.5M | $52.0M | ||
| Q3 24 | $71.6M | $58.0M | ||
| Q2 24 | $81.1M | $66.2M | ||
| Q1 24 | $80.5M | $65.1M |
| Q4 25 | $29.2M | $-10.6M | ||
| Q3 25 | $50.8M | $-8.5M | ||
| Q2 25 | $20.7M | $-34.2M | ||
| Q1 25 | $26.0M | $-11.6M | ||
| Q4 24 | $40.7M | $-707.0K | ||
| Q3 24 | $-91.5M | $2.3M | ||
| Q2 24 | $35.8M | $3.8M | ||
| Q1 24 | $-104.5M | $-5.0M |
| Q4 25 | — | 23.3% | ||
| Q3 25 | — | 28.0% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | — | 32.3% | ||
| Q2 24 | — | 28.8% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | 39.7% | -25.7% | ||
| Q3 25 | 82.8% | -18.9% | ||
| Q2 25 | 29.4% | -66.7% | ||
| Q1 25 | 39.7% | -11.9% | ||
| Q4 24 | 57.9% | -0.9% | ||
| Q3 24 | -127.8% | 1.0% | ||
| Q2 24 | 44.2% | 6.6% | ||
| Q1 24 | -129.6% | -5.9% |
| Q4 25 | 39.9% | -26.0% | ||
| Q3 25 | 82.4% | -19.2% | ||
| Q2 25 | 29.3% | -66.7% | ||
| Q1 25 | 39.5% | -22.9% | ||
| Q4 24 | 57.7% | -1.4% | ||
| Q3 24 | -127.9% | 4.0% | ||
| Q2 24 | 44.1% | 5.7% | ||
| Q1 24 | -129.8% | -7.7% |
| Q4 25 | $0.19 | $-0.50 | ||
| Q3 25 | $0.34 | $-0.41 | ||
| Q2 25 | $0.12 | $-1.65 | ||
| Q1 25 | $0.16 | $-0.56 | ||
| Q4 24 | $0.25 | $-0.03 | ||
| Q3 24 | $-0.69 | $0.11 | ||
| Q2 24 | $0.23 | $0.18 | ||
| Q1 24 | $-0.76 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $139.8M | $26.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.9B | $32.8M |
| Total Assets | $9.9B | $88.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $139.8M | $26.9M | ||
| Q3 25 | $245.9M | $36.1M | ||
| Q2 25 | $177.6M | $41.1M | ||
| Q1 25 | $166.4M | $54.7M | ||
| Q4 24 | $317.4M | $50.1M | ||
| Q3 24 | $194.3M | $52.0M | ||
| Q2 24 | $174.7M | $46.0M | ||
| Q1 24 | $161.2M | $55.3M |
| Q4 25 | $1.9B | $32.8M | ||
| Q3 25 | $1.9B | $43.1M | ||
| Q2 25 | $1.8B | $51.5M | ||
| Q1 25 | $1.9B | $85.1M | ||
| Q4 24 | $1.9B | $96.2M | ||
| Q3 24 | $1.9B | $96.4M | ||
| Q2 24 | $2.0B | $93.5M | ||
| Q1 24 | $2.0B | $96.7M |
| Q4 25 | $9.9B | $88.0M | ||
| Q3 25 | $9.5B | $100.3M | ||
| Q2 25 | $9.8B | $109.8M | ||
| Q1 25 | $8.8B | $148.7M | ||
| Q4 24 | $8.4B | $144.8M | ||
| Q3 24 | $9.1B | $146.0M | ||
| Q2 24 | $9.3B | $152.7M | ||
| Q1 24 | $9.2B | $169.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.5M | $-9.2M |
| Free Cash FlowOCF − Capex | — | $-9.2M |
| FCF MarginFCF / Revenue | — | -22.7% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | 4.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-23.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $142.5M | $-9.2M | ||
| Q3 25 | $31.7M | $-2.2M | ||
| Q2 25 | $63.2M | $-12.3M | ||
| Q1 25 | $39.3M | $7.0M | ||
| Q4 24 | $200.3M | $-1.2M | ||
| Q3 24 | $47.2M | $7.4M | ||
| Q2 24 | $50.2M | $-8.5M | ||
| Q1 24 | $52.8M | $7.1M |
| Q4 25 | — | $-9.2M | ||
| Q3 25 | — | $-4.8M | ||
| Q2 25 | — | $-13.6M | ||
| Q1 25 | — | $4.6M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $6.1M | ||
| Q2 24 | — | $-9.2M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | — | -22.7% | ||
| Q3 25 | — | -10.8% | ||
| Q2 25 | — | -26.5% | ||
| Q1 25 | — | 9.1% | ||
| Q4 24 | — | -3.7% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | — | -13.9% | ||
| Q1 24 | — | 9.0% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.9% |
| Q4 25 | 4.88× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 3.05× | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 4.93× | — | ||
| Q3 24 | — | 3.18× | ||
| Q2 24 | 1.40× | -2.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARI
Segment breakdown not available.
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
